Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma

Posterior reversible encephalopathy syndrome (PRES) is a rare but severe neurological syndrome that may stem from the use of some medications. Although its mechanism is not well-known, hypertension and endothelial dysfunction have been mentioned in previous literature as being related. Lenvatinib se...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Yu-Ju, Chen, Chun-Nan, Hong, Ruey-Long, Kung, Woon-Man, Huang, Abel Po-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856907/
https://www.ncbi.nlm.nih.gov/pubmed/36672016
http://dx.doi.org/10.3390/brainsci13010033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856907/
https://www.ncbi.nlm.nih.gov/pubmed/36672016
http://dx.doi.org/10.3390/brainsci13010033

Ejemplares similares